PROCEPT BioRobotics makes robotic systems that use imaging and a waterjet to remove prostate tissue, mainly for hospitals. It last closed at $23.78 on Nov 17, up 1.02% on the day. The average 12-month price target from 4 analysts is $24.25 (+2.0% from the last close), with a high of $30.00 and a low of $21.00. Analyst consensus is Hold, based on the latest ratings from 4 firms (1 buy, 3 hold, 0 sell).
Each firm's latest rating on PRCT in the past 90 days
Average 12-month target
$24.25
▲ 2.0% upside
Based on 4 analysts who set a price target on PRCT in the past 90 days. The average target is $24.25, with a high of $30.00 and a low of $21.00, compared with the last close of $23.78.
Low $21.00Avg $24.25High $30.00
Blue marker: last close $23.78
Highest target$30.00
Average target$24.25
Lowest target$21.00
Latest rating changes
Truist SecuritiesTarget lowered
Nov 6Hold$25 → $24
UBSMaintained
Nov 6Hold$21
Leerink PartnersTarget lowered
Nov 5Hold$29 → $22
BarclaysInitiated
Oct 7Buy$30
TD CowenMaintained
Aug 5Buy$28
Date
Firm
Action
Rating
Price target
Nov 6
Truist Securities
Target lowered
Hold
$25 → $24
Nov 6
UBS
Maintained
Hold
$21
Nov 5
Leerink Partners
Target lowered
Hold
$29 → $22
Oct 7
Barclays
Initiated
Buy
$30
Aug 5
TD Cowen
Maintained
Buy
$28
Loading…
Technical Analysis
PRCT · as of the Nov 17 close · updated after every close
Bounce inside a longer downtrend, nearing overbought
The stock is 11% above its 20 day and 18% above its 50 day average. It is 4% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 68), near overbought. The nearest support is the Pivot at $23.66, and the nearest resistance the swing high (Nov 5) at $24.07.
Short trendBullish
Long trendBearish
MomentumStrong
StretchNear overbought
VolatilityHigh, 5.4%/day
Key levels
$38.1152 week high+60.3%
$24.23Pivot R1+1.9%
$24.07Swing high (Nov 5)+1.2%
$23.78Last close
$23.66Pivot−0.5%
$23.22Pivot S1−2.4%
$22.85200 day average−3.9%
$21.1620 day average−11.0%
$20.69Swing low (Aug 20)−13.0%
$19.97100 day average−16.0%
$19.5850 day average−17.7%
$16.6752 week low−29.9%
Indicators
RSI (14)
67.89
Strong, overbought above 70
Neutral
MACD
1.25
Above its signal line
Bullish
Stochastic
88.9
Near the top of its range
Overbought
ADX (14)
40.3
Strong uptrend
Williams %R
-9.7
Oversold below −80, overbought above −20
Overbought
CCI (20)
107.6
Oversold below −100, overbought above 100
Overbought
Rate of change
+17.9%
Change over 10 sessions
Bullish
ATR (14)
$1.29
Typical daily range, 5.4% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumStrong
StretchNormal
VolatilityNormal, 11.9%/day
Key levels
$38.1152 week high+60.3%
$24.23Pivot R1+1.9%
$24.07Swing high (Nov 5)+1.2%
$23.78Last close
$23.66Pivot−0.5%
$23.22Pivot S1−2.4%
$22.85200 day average−3.9%
$21.1620 day average−11.0%
$20.69Swing low (Aug 20)−13.0%
$19.97100 day average−16.0%
$19.5850 day average−17.7%
$16.6752 week low−29.9%
Indicators
RSI (14)
55.09
Middle of its range
Neutral
MACD
-0.91
Above its signal line
Bullish
Stochastic
79.8
Middle of its range
Neutral
ADX (14)
20.6
Weak trend
Williams %R
-6.9
Oversold below −80, overbought above −20
Overbought
CCI (20)
159.8
Oversold below −100, overbought above 100
Overbought
Rate of change
+16.7%
Change over 10 sessions
Bullish
ATR (14)
$2.84
Typical daily range, 11.9% of price
MA 10Above
MA 20Above
MA 50Below
MA 100Below
MA 200–
What happened before, for PRCT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how PRCT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow PRCT usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How PRCT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PRCT is in one of them and how their past PRCT trades turned out.
PROCEPT BioRobotics makes surgical robots used to treat benign prostatic hyperplasia, a common condition in which the prostate gland enlarges and is not cancerous. Its AquaBeam and HYDROS robotic systems use a disposable handpiece, real time imaging and a waterjet that removes prostate tissue without heat. The company sells mainly to hospitals in the United States, with some sales through distribution partners, ambulatory surgery centers and leasing companies, and it sells to customers in other countries through its sales team and distribution partners. It is based in San Jose, California.